← Explorer/Network

Persistence of Immunoglobulin M or Immunoglobulin G Antibody Responses toBorrelia burgdorferi10–20 Years after Active Lyme Disease

Kalish RA, McHugh G, Granquist J +3 more2001Clinical Infectious DiseasesJournal Article
10.1086/322669PubMed
Immune/Innate
Lyme & Co-Infections

Abstract

The interpretation of serological results for patients who had Lyme disease many years ago is not well defined. We studied the serological status of 79 patients who had had Lyme disease 10-20 years ago and did not currently have signs or symptoms of active Lyme disease. Of the 40 patients who had had early Lyme disease alone, 4 (10%) currently had IgM responses to Borrelia burgdorferi, and 10 (25%) still had IgG reactivity to the spirochete, as determined by a 2-test approach (enzyme-linked immunosorbent assay and Western blot). Of the 39 patients who had had Lyme arthritis, 6 (15%) currently had IgM responses and 24 (62%) still had IgG reactivity to the spirochete. IgM or IgG antibody responses to B. burgdorferi may persist for 10-20 years, but these responses are not indicative of active infection.

Key Biomarkers

Immunoglobulin G antibody response to Borrelia burgdorferiImmunoglobulin M antibody response to Borrelia burgdorferi

Cited By (2)

  • Prospective Study of Serologic Tests for Lyme DiseaseClinical Infectious Diseases · 2000
  • Differential diagnoses of suspected Lyme Borreliosis or post-Lyme-disease syndromeEuropean Journal of Clinical Microbiology & Infectious Diseases · 2007

References (6)

  • The early clinical manifestations of Lyme diseaseAnnals of Internal Medicine · 1983
  • Treatment of the early manifestations of Lyme diseaseAnnals of Internal Medicine · 1983
  • Musculoskeletal and neurologic outcomes in patients with previously treated Lyme diseaseAnnals of Internal Medicine · 1999
  • Successful Parenteral Penicillin Therapy of Established Lyme ArthritisNew England Journal of Medicine · 1985
  • The clinical evolution of Lyme arthritis

Related Papers

  • Herbal Therapeutics for CIRS Biomarkers in Autism Spectrum Disorders: A Mechanistic and Molecular Approach for Neuroimmune Pathology in PediatricsMedical Research Archives · 2025 · 2 shared tags
  • Exploring Structured Camel Milk Therapy Alongside an Individualised Botanical Support Protocol to Facilitate Immune Modulation in a Child Diagnosed with PANS/PANDAS Co-Morbid with Lyme Disease and AutismJournal of Camel Practice and Research · 2025 · 2 shared tags
  • Neuroplasticity Intervention, Amygdala and Insula Retraining (AIR), Significantly Improves Overall Health and Functioning Across Various Chronic Conditions.PubMed · 2023 · 2 shared tags
  • Introduction to Chronic Inflammatory Response Syndrome (CIRS)2023 · 2 shared tags
  • TUBB1, TUBA4A and MAPK as Indicators of Die-Back Degenerative Central Nervous System Disease in Patients Sickened by Specific Exposure to the Interior Environment of Water- Damaged BuildingsMedical Research Archives · 2023 · 2 shared tags
  • Autism Spectrum Disorders and Lyme Disease: Exploring Shared Neuro-Inflammatory and Immune Pathways
Annals of Internal Medicine · 1987
  • Neurologic Abnormalities of Lyme Disease: Successful Treatment with High-Dose Intravenous PenicillinAnnals of Internal Medicine · 1983
  • Medical Research Archives · 2025 · 2 shared tags